Endoscopy 2022; 54(S 01): S30-S31
DOI: 10.1055/s-0042-1744619
Abstracts | ESGE Days 2022
ESGE Days 2022 Oral presentations
15:00–16:00 Thursday, 28 April 2022 South Halls 2 (A&B). Colorectal Cancer (CRC) Screening (WEO-ESGE joint session)

COLORECTAL CANCER RISK AND ADENOMA DETECTION RATE IN IMMUNOCHEMICAL FAECAL TEST SCREENING PROGRAMS

G. Antonelli
1   Ospedale dei Castelli Hospital, Department of Gastroenterology and Digestive Endoscopy, Rome, Italy
2   Sapienza University of Rome, Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Rome, Italy
,
M. Zorzi
3   Azienda Zero, Veneto Tumor Registry, Padova, Italy
,
J. Battagello
3   Azienda Zero, Veneto Tumor Registry, Padova, Italy
,
C. Hassan
4   Humanitas University, Department of Biomedical Sciences, Rozzano (MI), Italy
› Author Affiliations
 

Aims Colorectal Cancer (CRC) screening programs based on Faecal Immunochemical Test (FIT) represent the standard of care for population-based intervention. Its benefit depends on identification of neoplasia at colonoscopy in FIT+subjects. Thus, its quality as measured by Adenoma Detection Rate (ADR) may affect its outcomes.

Methods We performed a retrospective cohort study on patients undergoing colonoscopy after FIT+within a CRC-screening program between 2003 and 2017 in Italy. We recovered data on CRC diagnosed and CRC deaths observed between 6 months and 10 years after colonoscopy. Risk of interval-CRC incidence and mortality was assessed according to endoscopists’ ADR and advanced-ADR quintiles. Estimation of hazard ratio (HR) was adjusted for sex and age.

Results Overall, we included 68,604 colonoscopies performed by 133 endoscopists. After 295,081 person/years of follow up, 289 interval-CRCs were identified, resulting in 42 CRC-related deaths. Mean ADR was 48% (range 8-87%). When subdividing endoscopists by ADR quintile, unadjusted risk of interval-CRC from lowest to highest was 11.4, 9.7, 7.6, 11.4 and 9.5 per 10,000 person/years of follow up. No difference in CRC incidence and mortality between endoscopists in the lowest ADR quintile and the highest (aHR for CRC incidence/mortality: 0.80 [95%CI 0.52-1.23]/0.56 [95%CI 0.19-1.62]). Similar findings were observed using advanced ADR quintiles (aHR for CRC incidence/mortality: 1.03 [95%CI 0.67-1.57]/1.49 [95%CI 0.55-4.06]).

Table 1

CRC Incidence

CRC Mortality

Sex

Female

1.00

–0.95

1.00

–0.63

Male

1.20

– 1.53

1.18

– 2.20

Age (years)

50-59

1.00

–1.39

1.00

–0.75

60-70

1.77

– 2.27

1.40

– 2.60

ADR quintile

1 st

1.00

–0.51 – 1.14

1.00

–0.12 – 1.19

2 nd

0.76

0.44 – 1.00

0.39

0.27 – 1.79

3 rd

0.66

0.60 – 1.34

0.70

0.36 – 2.14

4 th

0.90

0.52 – 1.23

0.87

0.19 – 1.62

5 th

0.80

0.56

AADR quintile

1 st

1.00

–0.75 – 1.71

1.00

–0.29 – 2.83

2 nd

1.13

0.57 – 1.29

0.91

0.19 – 1.88

3 rd

0.86

0.81 – 1.83

0.60

0.61 – 4.31

4 th

1.22

0.67 – 1.57

1.63

0.54 – 4.05

5 th

1.03

1.49

Zoom Image
Fig. 1

Conclusions The lack of association between ADR and CRC incidence and mortality, as well as the low risk of interval CRC due to incomplete resection, supports the incorporation of colonoscopy resources within a programmatic intervention.



Publication History

Article published online:
14 April 2022

© 2022. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany